glp-1 from china China's landscape Semaglutide weight loss indication approved

[DOI] [PMC free article] [PubMed] [Google Scholar] 55.Rowlands J., Heng J., Newsholme P., Carlessi R

Proceed at your own risk.

GLP-1RA are only authorised for and used in the study setting in individuals with a BMI 30

Clinical reviews examining nutritional intake patterns in individuals using GLP-1 receptor agonists highlight predictable areas where support may be needed, particularly when reduced intake is sustained over time

If you could wave a wand and have an agency solve one commercialisation challenge for GLP1s this year, what would it be

SOURCE: The Wall Street Journal , April 1, 2025 Copyright 2025 HealthDay